Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Chief Tech/Sci/R&D Officer - 2009-07-16
Director of Finance/CFO 60 2022-06-30
Director TitleAgeSince
Director/Board Member 58 2020-07-08
Chairman 68 2021-12-08
Director/Board Member 78 2004-08-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/9/20 Tender

Chief Executive Officer

29,206 0.1196%
7/9/20 Tender

Chief Financial Officer

500 0.0020% -
7/9/20 Tender

Director

102,200 0.4187%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+2.84% - - 1.41M
+1.71%+2.69%-14.59%+14.50% 181B
-4.96%-3.59%-19.74%+12.78% 120B
+0.03%+1.94%+6.91%+39.00% 119B
+3.42%+1.71%-42.32%+9.52% 91.44B
+1.15%+1.18%-1.85%+80.63% 63.07B
-0.46%-0.64%+9.87%+80.82% 55.8B
+0.06%-0.31%+10.54%-21.03% 54.03B
-2.28%+0.51%-10.39%+42.08% 45.38B
+0.58%+2.00%-1.07%-6.43% 34.37B
Average -0.09%+0.48%-6.96%+27.99% 84.83B
Weighted average by Cap. -0.01%+0.76%-9.89%+25.94%
Logo TearLab Corporation
TearLab Corporation is an in-vitro diagnostic company. The Company has commercialized a tear testing platform, the TearLab Osmolarity System, which enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. The Company, through its subsidiary TearLab Research, Inc., develops technologies to enable eye care practitioners to test a range of biomarkers (chemistries, metabolites, genes and proteins) at the point-of-care. Its product, the TearLab Osmolarity System, enables the measurement of tear osmolarity in the doctor's office. The TearLab Osmolarity System consists of approximately three components: the TearLab disposable, the TearLab Pen, and the TearLab Reader. The TearLab disposable is a single-use microfluidic microchip. The TearLab Pen is a hand-held device that interfaces with the TearLab disposable. The TearLab Reader is a small desktop unit that allows for the docking of the TearLab Pen.
Employees
-